自血疗法联合布地奈德福莫特罗治疗支气管哮喘临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R562.2+5

基金项目:

深圳市福田区卫生公益性科研项目(FTWS2021060)


Clinical Study on Combination Use of Autohemotherapy and Budesonide and Formoterol for Bronchial Asthma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察自血疗法联合布地奈德福莫特罗治疗支气管哮喘(BA) 的临床疗效。方法:选取 100例BA患者,采用随机数字表法分为治疗组和对照组,每组50例。对照组给予布地奈德福莫特罗治疗,治 疗组在此基础上给予自血疗法治疗。比较2组临床疗效、症状评分、哮喘控制测试(ACT) 评分、免疫功能指 标、肺功能指标及不良反应发生率。结果:治疗后,治疗组总有效率92.00%,高于对照组82.00%,差异有统 计学意义(P<0.05)。治疗后,2组症状评分均较治疗前降低,治疗组症状评分低于对照组,差异均有统计学 意义(P<0.05)。治疗后,2组ACT评分均较治疗前升高,治疗组ACT评分高于对照组,差异均有统计学意 义(P<0.05)。治疗后,2 组免疫球蛋白E (IgE)、CD3+及CD4+水平均较治疗前降低,治疗组IgE、CD3+及 CD4+水平均低于对照组,差异均有统计学意义(P<0.05)。2组CD8+水平同组治疗前后及治疗后组间比较,差 异均无统计学意义(P>0.05)。治疗后,2组用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、呼气峰流 速(PEF) 水平均较治疗前升高,治疗组FVC、FEV1、PEF水平均高于对照组,差异均有统计学意义(P< 0.05)。治疗过程中,2组不良反应发生率均为8.00%,组间比较,差异无统计学意义(P>0.05)。结论:自血 疗法联合布地奈德福莫特罗治疗BA临床疗效较好,能有效缓解患者的临床症状,抑制气道炎症反应,提高机 体免疫力,改善肺功能,且安全性好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the combination use of autohemotherapy and Budesonide and Formoterol on bronchial asthma (BA). Methods:A total of 100 cases of BA patients were assigned to the treatment group and the control group according to the random number table method,with 50 cases in each group. The control group was treated with Budesonide and Formoterol,and the treatment group was additionally treated with autohemotherapy based on the treatment of the control group. The clinical effects, scores of symptoms and Asthma Control Test (ACT), levels of immune function indexes and lung function indexes, and incidence of adverse reactions were compared between the two groups. Results:After treatment,the total effective rate was 92.00% in the treatment group,higher than that of 82.00% in the control group, the difference being significant (P<0.05). After treatment, the scores of symptoms in both groups were reduced when compared with those before treatment, and the symptom scores in the treatment group was lower than that in the control group,differences being significant (P< 0.05). After treatment,the ACT scores in the two groups were elevated when compared with those before treatment,and the ACT score in the treatment group was higher than that in the control group,differences being significant (P<0.05). After treatment,the levels of immunoglobulin E (IgE),CD3+ and CD4+ in both groups were dwindled when compared with those before treatment, and the above three levels in the treatment group were lower than those in the control group,differences being significant (P<0.05). There was no significant difference being found in the comparison of level of CD8+ within the same group before and after treatment and between the two groups after treatment (P>0.05). After treatment,the levels of forced expiratory capacity (FVC), forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) in the two groups were up-regulated when compared with those before treatment, and the above three levels in the treatment group were higher than those in the control group, differences being significant (P<0.05). During the treatment, the incidence of adverse reaction was 8.00% in both groups, there being no significance in the difference (P>0.05). Conclusion: The combination use of autohemotherapy and Budesonide and Formoterol has a great curative effect on BA,which can effectively mitigate the clinical symptoms of patients, inhibit the airway inflammatory responses and enhance the immunity and the lung function with great safety.

    参考文献
    相似文献
    引证文献
引用本文

周龙健,顾凤群,王俏,吴泽铭,张智伟,张君成,刘映霞,马玉安.自血疗法联合布地奈德福莫特罗治疗支气管哮喘临床研究[J].新中医,2024,56(18):152-156

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-09-27
  • 出版日期:
文章二维码